|
[1]丁巧云, 张汉荣.拉米夫定治疗慢乙肝致重型肝炎的临床分析[J].临床肝胆杂志, 2003, 19 (6) ∶351-352.
|
|
[2]Price JS, France AJ, Moaven LD, et al.Foscarnet in fulminant hep-atitis B[J].Lancet, 1986, 2∶1273.
|
|
[3]Chen YJ, Gu JR, Jiang HC.Direct decection of serum HBVDNAbyspot hybridization[J].Chin J Infect Dis, 1983, 1∶63-67.
|
|
[4]Yao Y, Tang N, Huang A.Study on the replication of hepatitis B vi-rus compared with that of duck hepatitis B virus in primary duck hep-atocytes[J].Zhonghua Yi Xue Za Zhi, 2001, 81∶1157-1161.
|
|
[5]Lai C L, Ratziu V, Yuen M F, et al.Viral hepatitis B[J].Lancet2003, 362∶2089-2094.
|
|
[6]Hess G, Arnold W, Meyer zum Buschenfelde K H.Inhibition ofhepatitis B virus polymerase by phosphonoformate:studies on itsmode of action[J].J Med Virol, 1980, 5∶309-316.
|
|
[7]Honkoop P, de Man R A, Niesters HG, et al.Quantitative hepatitisB virus DNA assessment by the limiting-dilution polymerase chainreaction in chronic hepatitis B patients:evidence of continuing viralsuppression with longer duration and higher dose of lamivudine thera-py[J].J Viral Hepat, 1998, 5∶307-312.
|
|
[8]MacGregor R R, Graziani A L, Weiss R, et al.Successful foscarnettherapy for cytomegalovirus retinitis in an AIDS patient undergoinghemodialysis:rationale for empiric dosing and plasma level monito-ring[J].J Infect Dis, 1991, 164∶785-787.
|
|
[9]Freiman J S, Murray S M, Vickery K, et al.Postexposure treatmentof experimental DHBV infection:a new therapeutic strategy[J].JMed Virol, 1990, 30∶272-276.
|
|
[10]McMillan J S, Shaw T, Angus P W, et al.Effect of immunosup-pressive and antiviral agents on hepatitis B virus replication in vitro[J].Hepatology, 1995, 22∶36-43.
|
PDF下载 ( 264 KB)
本文二维码
下载:
